{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:36:12Z","timestamp":1784324172458,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SIR\/\/2022\/000019"],"award-info":[{"award-number":["SIR\/\/2022\/000019"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SIR\/000019\/2021"],"award-info":[{"award-number":["SIR\/000019\/2021"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.pharma.2023.10.005","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:14:41Z","timestamp":1697800481000},"page":"446-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["D-optimal mixture design inspired modified release tablet formulation of lamotrigine for the treatment of seizures: An in-depth characterization"],"prefix":"10.1016","volume":"82","author":[{"given":"Umesh","family":"Atneriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Sainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay R.","family":"Chidrawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-9461","authenticated-orcid":false,"given":"Rahul","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2023.10.005_bib0295","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/epi.17165","article-title":"The global cost of epilepsy: a systematic review and extrapolation","volume":"63","author":"Begley","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharma.2023.10.005_bib0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.pharma.2023.10.005_bib0305","first-page":"163","article-title":"Seizures, emergency medical services: clinical practice and systems oversight","volume":"1","author":"Huff","year":"2021","journal-title":"StatPearls"},{"key":"10.1016\/j.pharma.2023.10.005_bib0310","first-page":"151","article-title":"Formulation and evaluation of controlled release tablet of lamotrigine","volume":"9","author":"Swati","year":"2018","journal-title":"Int J Pharm Biol Arch"},{"key":"10.1016\/j.pharma.2023.10.005_bib0315","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40262-017-0614-5","article-title":"Effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for maintenance dose optimisation in future clinical trials","volume":"57","author":"van Dijkman","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharma.2023.10.005_bib0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/FPC.0000000000000397","article-title":"PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics","volume":"30","author":"Mitra-Ghosh","year":"2020","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.pharma.2023.10.005_bib0325","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WCO.0000000000000532","article-title":"Intelligent use of antiepileptic drugs is beneficial to patients","volume":"31","author":"Cheng","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.pharma.2023.10.005_bib0330","series-title":"Design and analysis of simulation experiments","author":"Kleijnen","year":"2018"},{"key":"10.1016\/j.pharma.2023.10.005_bib0335","series-title":"Drug targeting and stimuli sensitive drug delivery systems","first-page":"567","article-title":"Oral controlled and sustained drug delivery systems: concepts, advances, preclinical, and clinical status","author":"Kaur","year":"2018"},{"key":"10.1016\/j.pharma.2023.10.005_bib0340","series-title":"Flavors for Nutraceutical and Functional Foods","first-page":"95","article-title":"Natural Ingredients\/Botanical Extracts for the Nutraceutical Industry","author":"Maheshwari","year":"2018"},{"key":"10.1016\/j.pharma.2023.10.005_bib0345","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jddst.2017.10.010","article-title":"Synthesis and evaluation of pH dependent polyethylene glycol-co-acrylic acid hydrogels for controlled release of venlafaxine HCl","volume":"43","author":"Ijaz","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2023.10.005_bib0350","series-title":"Drug delivery systems","first-page":"615","article-title":"Specialized tablets: ancient history to modern developments","author":"Advankar","year":"2019"},{"key":"10.1016\/j.pharma.2023.10.005_bib0355","first-page":"192","article-title":"Microsponge embedded tablets for sustained delivery of nifedipine","volume":"5","author":"Maheshwari","year":"2017","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.pharma.2023.10.005_bib0360","series-title":"Drug delivery systems","first-page":"1","article-title":"Fundamentals of diffusion and dissolution: dissolution testing of pharmaceuticals","author":"Kapoor","year":"2020"},{"key":"10.1016\/j.pharma.2023.10.005_bib0365","series-title":"Dosage form design considerations","first-page":"287","article-title":"Dissolution profile consideration in pharmaceutical product development","author":"Mehtani","year":"2018"},{"key":"10.1016\/j.pharma.2023.10.005_bib0370","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejps.2018.09.006","article-title":"Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: effect of dosage form design","volume":"124","author":"Lugtu-Pe","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0375","article-title":"Scalable Design and Development of Modified Release Hydrochlorothiazide Formulation Employing Quality by Design Approach","volume":"84","author":"Singhai","year":"2022","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.pharma.2023.10.005_bib0380","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jconrel.2020.05.045","article-title":"Hypromellose\u2013A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery","volume":"324","author":"Ma\u0161kov\u00e1","year":"2020","journal-title":"Journal of controlled release"},{"key":"10.1016\/j.pharma.2023.10.005_bib0385","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection\u00a0\u2013\u00a0a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biomet J"},{"key":"10.1016\/j.pharma.2023.10.005_bib0390","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/17425247.2018.1504768","article-title":"Quality by Design (QbD) approaches in current pharmaceutical set-up","volume":"15","author":"Mishra","year":"2018","journal-title":"Exp Opin Drug Deliv"},{"key":"10.1016\/j.pharma.2023.10.005_bib0395","series-title":"Dosage Form Design Parameters","first-page":"221","article-title":"Bulk level properties and its role in formulation development and processing","author":"Moondra","year":"2018"},{"key":"10.1016\/j.pharma.2023.10.005_bib0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.29161\/PT.v7.i2.2019.35","article-title":"Study of post compression parameters of various marketed paracetamol tablets in India","volume":"7","author":"Nayak","year":"2019","journal-title":"Pharma Tutor"},{"key":"10.1016\/j.pharma.2023.10.005_bib0405","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/pharmaceutics11080400","article-title":"Fast, spectroscopy-based prediction of in vitro dissolution profile of extended release tablets using artificial neural networks","volume":"11","author":"Galata","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2023.10.005_bib0410","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2018.04.011","article-title":"Design and optimization of gastro-floating sustained-release tablet of pregabalin: in vitro and in vivo evaluation","volume":"545","author":"Qin","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2023.10.005_bib0415","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/03639045.2019.1665062","article-title":"A review of methods for solubility determination in biopharmaceutical drug characterization","volume":"45","author":"Veseli","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2023.10.005_bib0420","doi-asserted-by":"crossref","first-page":"117935","DOI":"10.1016\/j.molliq.2021.117935","article-title":"Solubility study of lamotrigine in the aqueous mixture of choline chloride based deep eutectic solvent at different temperatures","volume":"344","author":"Zarghampour","year":"2021","journal-title":"J Mol Liquids"},{"key":"10.1016\/j.pharma.2023.10.005_bib0425","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.52711\/0974-360X.2022.00576","article-title":"Studies on drug compatibility with different pharmaceutical excipients in nanoparticle formulation","volume":"15","author":"Devi","year":"2022","journal-title":"Res J Pharm Technol"},{"key":"10.1016\/j.pharma.2023.10.005_bib0430","first-page":"56: 216","article-title":"Development and in vitro evaluation of atazanavir microcrystals for intranasal delivery","author":"Paul","year":"2022","journal-title":"Indian J Pharm Educ Res"},{"key":"10.1016\/j.pharma.2023.10.005_bib0435","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1208\/s12249-017-0861-7","article-title":"Effects of the preparation process on the properties of amorphous solid dispersions","volume":"19","author":"Huang","year":"2018","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.pharma.2023.10.005_bib0440","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.3390\/molecules24234315","article-title":"Application of solid dispersion technique to improve solubility and sustain release of emamectin benzoate","volume":"24","author":"Huang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharma.2023.10.005_bib0445","first-page":"234","article-title":"Solid dispersions: a review","author":"Dhirendra","year":"2009","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0450","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jps.2600550211","article-title":"Micromeritics of granular pharmaceutical solids I: physical properties of particles prepared by five different granulation methods","volume":"55","author":"Fonner","year":"1966","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0455","doi-asserted-by":"crossref","first-page":"107418","DOI":"10.1016\/j.mtcomm.2023.107418","article-title":"Comparing deep freezing, flash freezing and annealing induced materialistic changes during the formulation of alanine and serine monomers mediated fast disintegrating tablets","volume":"37","author":"Maheshwari","year":"2023","journal-title":"Materials Today Communications"},{"key":"10.1016\/j.pharma.2023.10.005_bib0460","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1208\/s12249-013-9994-5","article-title":"Note on the measurement of bulk density and tapped density of powders according to the European Pharmacopeia","volume":"14","author":"Silva","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2023.10.005_bib0465","doi-asserted-by":"crossref","first-page":"57212","DOI":"10.1039\/C5RA07197F","article-title":"Understanding empirical powder flowability criteria scaled by Hausner ratio or Carr index with the analogous viscosity concept","volume":"5","author":"Hao","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.pharma.2023.10.005_bib0470","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.powtec.2018.02.003","article-title":"A review on the angle of repose of granular materials","volume":"330","author":"Al-Hashemi","year":"2018","journal-title":"Powder Technol"},{"key":"10.1016\/j.pharma.2023.10.005_bib0475","series-title":"Dosage Form Design Parameters","first-page":"1","article-title":"Levels of Solid State Properties: Role of Different Levels During Pharmaceutical Product Development","author":"Maheshwari","year":"2018"},{"key":"10.1016\/j.pharma.2023.10.005_bib0480","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0897190012442716","article-title":"Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice","volume":"25","author":"Tahaineh","year":"2012","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.pharma.2023.10.005_bib0485","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jps.2600540926","article-title":"Evaluation of the physical properties of compressed tablets I: tablet hardness and friability","volume":"54","author":"Seitz","year":"1965","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0490","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2015.02.061","article-title":"Validation and applications of an expedited tablet friability method","volume":"484","author":"Osei-Yeboah","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2023.10.005_bib0495","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4172\/2155-9872.1000151","article-title":"UV-visible spectrophotometric method development and validation of assay of paracetamol tablet formulation","volume":"3","author":"Behera","year":"2012","journal-title":"J Anal Bioanal Tech"},{"key":"10.1016\/j.pharma.2023.10.005_bib0500","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-5173(97)00117-8","article-title":"Optimization of hydrophilic matrix tablets using a D-optimal design","volume":"153","author":"Bodea","year":"1997","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2023.10.005_bib0505","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s001689900010","article-title":"Hypothesis testing in hedonic price estimation\u00a0\u2013\u00a0on the selection of independent variables","volume":"34","author":"Andersson","year":"2000","journal-title":"Ann Reg Sci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0510","first-page":"4","article-title":"Variable selection with stepwise and best subset approaches","author":"Zhang","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.pharma.2023.10.005_bib0515","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fnins.2019.00895","article-title":"A systematic review of paired associative stimulation (PAS) to modulate lower limb corticomotor excitability: implications for stimulation parameter selection and experimental design","volume":"13","author":"Alder","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0520","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1208\/pt0804101","article-title":"Design and study of lamivudine oral controlled release tablets","volume":"8","author":"Ravi","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2023.10.005_bib0525","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0378-5173(02)00577-X","article-title":"Evaluation of solid dispersion particles prepared with SEDS","volume":"250","author":"Juppo","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2023.10.005_bib0530","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejpb.2009.11.010","article-title":"Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro\u2013in vivo evaluation in healthy human volunteers","volume":"74","author":"Tadros","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2023.10.005_bib0535","first-page":"526","article-title":"Post-compression evaluation parameters for tablets\u00a0\u2013\u00a0an overview","volume":"4","author":"Chaturvedi","year":"2017","journal-title":"Eur J Pharm Med Res"},{"key":"10.1016\/j.pharma.2023.10.005_bib0540","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1018921830385","article-title":"A floating controlled-release drug delivery system: in vitro\u2013in vivo evaluation","volume":"10","author":"Desai","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharma.2023.10.005_bib0545","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-3659(02)00490-X","article-title":"Development and validation of an in vitro\u2013in vivo correlation for buspirone hydrochloride extended release tablets","volume":"88","author":"Takka","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2023.10.005_bib0550","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/156720109787048258","article-title":"Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets","volume":"6","author":"Shrivastava","year":"2009","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.pharma.2023.10.005_bib0555","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jps.2600620336","article-title":"Differential thermal analysis and X-ray diffraction studies of griseofulvin-succinic acid solid dispersions","volume":"62","author":"Chiou","year":"1973","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0560","first-page":"822","article-title":"Surface solid dispersion of glimepiride for enhancement of dissolution rate","volume":"1","author":"Kiran","year":"2009","journal-title":"Int J Pharm Tech Res"},{"key":"10.1016\/j.pharma.2023.10.005_bib0565","series-title":"Annales pharmaceutiques fran\u00e7aises","first-page":"284","article-title":"In vitro profiling of fenofibrate solid dispersion mediated tablet formulation to treat high blood cholesterol","author":"Atneriya","year":"2023"},{"key":"10.1016\/j.pharma.2023.10.005_bib0570","first-page":"12","article-title":"Release kinetics\u00a0\u2013\u00a0concepts and applications","volume":"8","author":"Paarakh","year":"2018","journal-title":"Int J Pharm Res Technol"},{"key":"10.1016\/j.pharma.2023.10.005_bib0575","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/js9600538","article-title":"Modeling of drug release from erodible tablets","volume":"86","author":"Katzhendler","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharma.2023.10.005_bib0580","first-page":"2013","article-title":"Formulation development and stability studies of norfloxacin extended-release matrix tablets","author":"Oliveira","year":"2013","journal-title":"BioMed Res Int"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:41:17Z","timestamp":1777390877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450923001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0003450923001128"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2023.10.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D-optimal mixture design inspired modified release tablet formulation of lamotrigine for the treatment of seizures: An in-depth characterization","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2023.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}